Institute for Cancer Research

Analysis

Institute for Cancer Research is a registered charity in United States, based in Philadelphia, PA. It received its IRS tax-exemption ruling in December 1944, 82 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a hospital or medical research organisation under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending June 2023, Institute for Cancer Research reported income of $98.8m and spending of $90.5m, spending 92% of its income. Across the 5 years on record, from June 2019 to June 2023, income grew from $83.0m to $98.8m (+19%), an average of +4.4% a year. The sharpest change came in the year to June 2022, when income rose by 19%. Over the whole period it spent 96% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Institute for Cancer Research sits at the 95th percentile: it is larger than about 95% of them. Against every charity in United States with reported income it ranks in the 99th percentile, and in the 99th percentile within PA. Charities of a similar size with the same main cause include Northbay Healthcare Corporation ($98.7m), Cascadia Health ($98.9m) and Longmont United Hospital ($98.6m).

On its Form 990 for the period ending June 2023, revenue came from contributions and grants 55% and program service revenue 43% of the total. Compensation of current officers, directors and key employees was $114k (0.1% of expenses). Other salaries and wages came to $47.4m. At year end it held assets of $164.3m against liabilities of $55.9m, net assets of $108.4m. It reported 717 employees.